Aditxt, Inc. Preferred Stock, Value, Issued
Aditxt, Inc. (ADTX) had Preferred Stock, Value, Issued of $2.60 million as of 2025-01-01, per its 10-K filed 2025-03-31.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:PreferredStockValue · last filed 2025-03-31
- 2025-01-01: Preferred Stock, Value, Issued $2.60M.
- 2023-07-11: Preferred Stock, Value, Issued $1.00K.
| Period end | Preferred Stock, Value, Issued |
|---|---|
| 2025-01-01 | $2.60M 10-K · filed 2025-03-31 |
| 2023-07-11 | $1.00K 10-Q · filed 2023-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |